Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Crohn'S & Colitis|September 24, 2016
The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel DiseasesCarolijn Smids, Carmen S Horjus Talabur Horje, Femke van Wijk, et al.Nederlands Tijdschrift Voor Geneeskunde|February 26, 2015
[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]Chantal E Mulkens, Ellen G van Lochem, Claudia C Folman, et al.Nutrients|May 14, 2022
Dose-Escalating (50-500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled TrialJordy P W Burger, Ellen G van Lochem, Elisabeth A Roovers, et al.Inflammatory Bowel Diseases|October 1, 2014
On naivety of T cells in inflammatory bowel disease: a reviewCarolijn Smids, Carmen S Horjus Talabur Horje, Peter J Wahab, et al.Inflammatory Bowel Diseases|April 9, 2016
Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel DiseaseCarmen S Horjus Talabur Horje, Jos Meijer, Lian Rovers, et al.Journal of Crohn'S & Colitis|April 4, 2017
Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease CourseCarolijn Smids, Carmen S Horjus Talabur Horje, Stefan Nierkens, et al.Inflammatory Bowel Diseases|March 29, 2019
Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-upBritt Roosenboom, Peter J Wahab, Carolijn Smids, et al.Scandinavian Journal of Gastroenterology|June 30, 2017
The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patientCarolijn Smids, Carmen S Horjus Talabur Horje, Marcel J M Groenen, et al.Inflammatory Bowel Diseases|September 24, 2014
Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel diseaseCarmen S Horjus Talabur Horje, Sabine Middendorp, Elly van Koolwijk, et al.Clinical Immunology (Orlando, Fla.)|January 10, 2008
Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosisMichiel Heron, Walentina A T Slieker, Pieter Zanen, et al.Pageof 3